Mobile
  • Search
  • Advanced search
  • Multi-criteria search
  • Who are we ?
  • Log in
  • Sign up
  • Français
  • English

Kusajili – Clinical trials directory

Your research

Clear all filters

Filtres
organs
Specialty
Type
Promoter
  • AZIENDA OSPEDALIERA S. LUIGI GONZAGA (1)
Country
Source
  • euctr (1)
Phase
  • ongoing (1)

Promoter: AZIENDA OSPEDALIERA S. LUIGI GONZAGA
AZIENDA OSPEDALIERA S. LUIGI GONZAGA Update Il y a 4 ans

phase II study of the combination of bevacizumab plus somatostatin analogue and metronomic capecitabine as first-line therapy in patients with advanced inoperable well-differentiated neuroendrocrine tumors To assess the antitumor activity in terms of objective response rate (RR) of bevacizumab in combination with somatostatin analogue and capecitabine administered on a metronomic schedule.

  • Country None
  • organs None
  • Specialty None
unknown
More information

  • 1

Who are we ?

Kusajili was created to respond to a request from physicians to simplify access to patient registries and inclusion. Kusajili is regularly updated according to new French and international trials. [email protected]

Kusajili and MyHomeDoctor

MyHomeDoctor software unique to the world, created with surgeons, for follow-up and analysis of patient follow-up. Kusajili and MyHomeDoctor partners, help clinical research through improved patient follow-up and automatic inclusion.

Sign up

Sign up
Français - English - CGU - Cookies

©2023 Kusajili France - Kusajili International - MedSynApps - MyHomeDoctor.